IVIG: The Heart Savior in Covid 19 era

Autor: Matina Hamadeh, Zouheir Kreidly, Amena Khatoun, Pierre Nassar, Claudette Najjar, Rima Chaddad, Malek Moussa
Rok vydání: 2021
Předmět:
Zdroj: Cardiology Research and Reports. 3:01-05
ISSN: 2692-9759
DOI: 10.31579/2692-9759/026
Popis: Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified as an outbreak in Wuhan City, Hubei Province, China [1]. Cases of multisystem inflammatory syndrome after Covid – 19 infection have been extensively documented in children. CDC reported 27 cases of multisystem inflammatory syndrome in adults (MIS-A) in direct reports through October 2020, as well as various case series and published case reports [2]. Cytokine storm, as a trigger of the progression of HF in patients with COVID-19, has become a novel focus to explore therapies for target populations [3]. In this article, we briefly present a case of a Covid-19 infection associated myocarditis complicated by acute heart failure successfully treated with IVIG.
Databáze: OpenAIRE